Advertisement

Topics

Alfa Chemicals Ltd Company Profile

22:02 EST 21st January 2019 | BioPortfolio

Alfa Chemicals Ltd. is one of the leading distributors of speciality chemicals throughout the UK & Ireland. Since its formation in 1976, we have remained independent and stuck closely to our fundamental premise of working in partnership with our Principals & Customers.

We are particularly strong in the following markets: Pharmaceutical, Personal Care, Nutraceutical, Plastics & Polyurethanes, Coatings & Inks, Cleaners & Polishes, Metal Working & Finishing. A range of services are offered that ensures Customers receive the level of care which industry requires & expects.

Location

Arc HouseTerrace Road South
Binfield
Bracknell
RG42 4PZ
United Kingdom

Contact

Phone: 01344 861 800
Fax: 01344 451 400
Email: info@alfa-chemicals.co.uk


News Articles [410 Associated News Articles listed on BioPortfolio]

Human medicines European public assessment report (EPAR): Pergoveris, follitropin alfa / lutropin alfa, Revision: 12, Authorised

New Zealand to fund only biosimilar epoetin alfa

New Zealand will stop funding the brand-name epoetin alfa biological Eprex and, in future, will only fund the biosimilar epoetin alfa Binocrit.

Epoetin Alfa Biosimilar Launched in United States at Discounted Cost

Epoetin alfa-epbx (Retacrit), the biosimilar to epoetin alfa (Procrit/Epogen) has been launched in the United States at a significant discount.

Pending EC decision: Epoetin Alfa Hexal, epoetin alfa, Opinion date: 26-Jul-2018

Alfa Laval Wins SEK 180 Million Pumping Orders

LUND, Sweden, Jan. 7, 2019 /PRNewswire/ -- Alfa Laval – a world leader in heat transfer, centrifugal separation and fluid handling – has won two Read more...

Verticroft - Alfa Hay Price Continues to Rise - 200 USD by 2019

DUBAI, UAE, October 1, 2018 /PRNewswire/ -- Verticroft, a world leader in VCC (vertical crop culture) and the largest producer of sustainable Alfa hay in Read more...

ESA Biosimilar Effective for Anemia in Hemodialysis Patients

Researchers found "no clinically meaningful differences" in efficacy and safety between the biosimilar epoetin alfa-epbx and epoetin alfa.

Abou-Alfa Highlights HCC Advances, Unmet Needs in Other GI Cancers

Ghassan K. Abou-Alfa, MD, discusses the rapidly evolving treatment options in hepatocellular carcinoma and other developments in gastrointestinal cancers.

Drugs and Medications [78 Associated Drugs and Medications listed on BioPortfolio]

Nitrogen [Air Products and Chemicals, Inc.]

NA

Helium [Air Products and Chemicals, Inc.]

NA

Oxygen [Air Products and Chemicals, Inc.]

NA

Ribavirin [Richmond Pharmaceuticals, Inc.]

These highlights do not include all the information needed to use ribavirin tablets safely and effectively. See full prescribing information for ribavirin tablets. Ribavirin Tablets for oral useInitia...

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. RIBAVIRIN tablets, for oral useIniti...

PubMed Articles [350 Associated PubMed Articles listed on BioPortfolio]

Switching from Epoetin Alfa (Epogen®) to Epoetin Alfa-Epbx (RetacritTM) Using a Specified Dosing Algorithm: A Randomized, Non-Inferiority Study in Adults on Hemodialysis.

For patients with anemia undergoing hemodialysis, erythropoiesis-stimulating agents (ESAs) are typically dosed via precise algorithms. Using one such algorithm, we assessed the maintenance of hemoglob...

Ovarian stimulation with corifollitropin alfa followed by hp-hMG compared to hp-hMG in patients at risk of poor ovarian response undergoing ICSI: A randomized controlled trial.

To compare the results of two ovarian stimulation protocols for IVF in patients at risk of poor ovarian response: corifollitropin alfa followed by hp-hMG versus daily administration of hp-hMG. We inte...

Correction to: Andexanet Alfa: First Global Approval.

The article Andexanet Alfa: First Global Approval, written by Young-A Heo, was originally published Online First without open access.

An easy-to-use baseline scoring system to predict response to peginterferon alfa-2a in patients with chronic hepatitis B in resource-limited settings.

Approximately one-third of patients have durable responses after finite (48-week) treatment with peginterferon alfa-2a. The ability to identify patients likely to respond would be particularly useful ...

HBsAg loss with Pegylated-interferon alfa-2a in hepatitis B patients with partial response to nucleos(t)-ide analog: new switch study.

Hepatitis B surface antigen (HBsAg) loss is seldom achieved with nucleos(t)ide analog (NA) therapy in chronic hepatitis B patients but may be enhanced by switching to finite pegylated-interferon (Peg-...

Clinical Trials [1155 Associated Clinical Trials listed on BioPortfolio]

Study Comparing Reduction and Viral Safety of IFN Alfa-2b XL + Ribavirin Versus PEG IFN Alfa-2b + Ribavirin in Patients With Chronic Hepatitis C Genotype 1

The purpose of this study is to confirm if IFN alfa-2b XL has a better antiviral activity and tolerability as compared with current marketed reference, while combined with ribavirin, in a ...

Cost-effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia

The purpose of this study is to evaluate the cost-effectiveness of epoetin alfa compared with darbepoetin alfa in the treatment of anemia in adults receiving chemotherapy for cancer. Epoe...

PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients

The purpose of this study is to demonstrate that once every-2-weeks and once every-4-weeks treatment with epoetin alfa, a drug that increases red blood cell production, in patients with an...

Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders

In an opened randomized study of women undergoing in vitro fertilization with expected suboptimal response to controlled ovarian stimulation (Poseidon Group 2b) investigators will examine ...

Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy

RATIONALE: Epoetin alfa and darbepoetin alfa may cause the body to make more red blood cells. They are used to treat anemia caused by chemotherapy in patients with cancer. PURPOSE: This r...

Companies [591 Associated Companies listed on BioPortfolio]

Alfa Chemicals Ltd

Alfa Chemicals Ltd. is one of the leading distributors of speciality chemicals throughout the UK & Ireland. Since its formation in 1976, we have remained independent and stuck closely to our fundament...

Alfa Laval

Alfa Laval is a leading global provider of specialized products and engineered solutions. Our equipment, systems and services are dedicated to helping customers to optimize the performance of their pr...

Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. is a leader in the development and manufacture of rapid, immunoassay, point-of-care tests. As a minority, woman-owned, small business, ALFA offers a ...

Assisted Living Federation of America (ALFA)

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors an...

Assisted Living Federation of America

The Assisted Living Federation of America (ALFA) is the largest national association exclusively dedicated to professionally managed assisted living communities and the seniors and families they serve...

More Information about "Alfa Chemicals Ltd" on BioPortfolio

We have published hundreds of Alfa Chemicals Ltd news stories on BioPortfolio along with dozens of Alfa Chemicals Ltd Clinical Trials and PubMed Articles about Alfa Chemicals Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alfa Chemicals Ltd Companies in our database. You can also find out about relevant Alfa Chemicals Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record